logo

CELZ

Creative Medical·NASDAQ
--
--(--)
--
--(--)
3.04 / 10
Netural

CELZ's fundamental score is 3.0/10, indicating sub-par quality. Key concerns include a low current assets turnover ratio and net profit/total profit percentage, though strong gross margin (60%) and fixed assets efficiency provide partial relief. Historical group analysis shows mixed one-month returns, suggesting uncertainty in fundamental-driven rallies.

Fundamental(3.04)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score2/3
Weight23.39%
1M Return11.69%
Inventory turnover ratio
Value0.75
Score2/3
Weight-3.89%
1M Return-2.63%
Gross profit margin (%)
Value60.00
Score2/3
Weight2.54%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight15.35%
1M Return7.79%
PB-ROE
Value0.39
Score1/3
Weight14.17%
1M Return7.02%
Current assets turnover ratio
Value0.00
Score0/3
Weight-2.81%
1M Return-1.88%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.31%
1M Return0.86%
Asset-MV
Value-0.50
Score2/3
Weight35.02%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight15.37%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.45%
1M Return-0.30%
Is CELZ fundamentally strong?
  • CELZ scores 3.04/10 on fundamentals and holds a Fair valuation at present. Backed by its -68.84% ROE, -99356.80% net margin, -0.84 P/E ratio, 0.89 P/B ratio, and 25.26% earnings growth, these metrics solidify its Netural investment rating.